Related Experiment Videos
C-type lectin-related proteins from snake venoms
1Department of Biochemistry, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose, Tokyo 204-8588, Japan. tmorita@my-pharm.ac.jp
Summary
Snake venom C-type lectin-like proteins (CLPs) exhibit diverse biological activities, influencing blood coagulation and platelet function. Their study reveals evolutionary insights and potential applications in understanding hemostasis and thrombosis.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- C-type lectin-like proteins (CLPs) in snake venom possess varied biological activities, including effects on blood coagulation and platelet activation.
- Structural and functional studies of CLPs, like factor IX/factor X-binding protein, offer insights into protein evolution via 3D domain swapping and the role of magnesium ions in coagulation.
Purpose of the Study:
- To explore the diverse biological functions of snake venom CLPs.
- To understand the evolutionary mechanisms of CLP diversification.
- To investigate the potential of CLPs in studying prothrombin, coagulation factor X, and platelet receptor interactions.
Main Methods:
- Isolation and characterization of snake venom CLPs.
- Structural and functional analysis of CLPs.
- Investigating CLP interactions with coagulation factors and platelet receptors.
Main Results:
- CLPs demonstrate anticoagulant, procoagulant, and platelet agonist/antagonist activities.
- Factor IX/factor X-binding protein studies revealed evolutionary pathways of CLPs through 3D domain swapping.
- Metallo-proteases carinactivase and RVV-X, containing CLPs, are valuable tools for studying prothrombin and factor X.
- Several unique CLPs were identified as modulators of platelet receptors (GP Ib, Ia/IIa, VI) and collagen receptors.
Conclusions:
- Snake venom CLPs are a rich source of molecules with significant hemostatic and platelet-modulating properties.
- CLPs provide novel insights into blood coagulation cascade mechanisms and platelet signaling pathways.
- These proteins hold potential for developing diagnostic tools and therapeutic agents targeting coagulation disorders and thrombosis.